Company intelligence / Profile preview

Baifan Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Baifan Biotechnology is a specialized biotechnology company focused on the research, development, and large-scale production of high-end cell culture media. Based in Shanghai, the company provides serum-free and chemically defined media solutions tailored for the manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and advanced therapies. In addition to its product portfolio, Baifan offers comprehensive CDMO services, including media formulation optimization and bioprocessing scale-up support. The company serves the global biopharmaceutical industry, aiming to enhance production efficiency and ensure the stability of biological drug manufacturing.

Modalities: BiologicMonoclonal antibodyVaccineCell therapyGene therapyRecombinant protein
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Baifan Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baifan Biotechnology.

Explore the full profile